ADENOCAP Trademark

Trademark Overview

On Friday, July 10, 2020, a trademark application was filed for ADENOCAP with the United States Patent and Trademark Office. The USPTO has given the ADENOCAP trademark a serial number of 90047807. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2024. This trademark is owned by ImmunityBio, Inc.. The ADENOCAP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; development of pharmaceuticals, diagnostics, vaccines and therapeutics for COVID-19 and human adenovirus infections; scientific research services for adenovirus vectors for gene therapy, vaccines and cancer therapy
adenocap

General Information

Serial Number90047807
Word MarkADENOCAP
Filing DateFriday, July 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Goods and ServicesScientific research services for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; development of pharmaceuticals, diagnostics, vaccines and therapeutics for COVID-19 and human adenovirus infections; scientific research services for adenovirus vectors for gene therapy, vaccines and cancer therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, August 8, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNANTCELL, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCULVER CITY, CA 90232
Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCulver City, CA 90232
Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCulver City, CA 90232

Trademark Events

Event DateEvent Description
Tuesday, July 14, 2020NEW APPLICATION ENTERED
Wednesday, February 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 4, 2021ASSIGNED TO EXAMINER
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 8, 2021SOU EXTENSION 1 FILED
Monday, November 8, 2021SOU EXTENSION 1 GRANTED
Thursday, May 12, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, November 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2022SOU EXTENSION 2 FILED
Thursday, May 12, 2022PETITION TO REVIVE-GRANTED
Thursday, May 12, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, June 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 11, 2022SOU EXTENSION 3 FILED
Friday, November 11, 2022SOU EXTENSION 3 GRANTED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 13, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, June 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 29, 2022SOU EXTENSION 2 GRANTED
Tuesday, November 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU EXTENSION 4 FILED
Monday, May 8, 2023SOU EXTENSION 4 GRANTED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023SOU EXTENSION 5 GRANTED
Thursday, November 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU EXTENSION 5 FILED

Related Keywords

adenocap adenovirus human scientific vaccines therapy covid infections services research therapeutics